World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
New F.D.A.: Transparence and Flexibility
Keywords:
Tags: Pharmaceutical,
FDA Advisory panel recommendations for pharmaceutical companies.
07/10/2006
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Signals It's Open To Drug Trials That Shift Midcourse
Wall Street Journal 07/10/2006
FDA to Hire Additional Scientists To Expand Drug Safety Operations
Wall Street Journal 04/30/2008
Panel Recommends Ban on 2 Popular Painkillers
New York Times 07/01/2009
F.D.A. Reveals It Fell to a Push by Lawmakers
New York Times 09/25/2009
Wall Street Journal 12/30/2009
FDA and the drug safety, production and marketing practices of pharmaceutical companies.
07/01/2005
The increasing controversy surrounding the safety and marketing of many pharmaceutical products and the role of the FDA in ensuring safe use and avoiding risks to users.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Plan Would Aid Drug Makers in Liability Suits
Wall Street Journal 01/14/2006
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
Financial Ties to Industry Cloud Major Depression Study
Wall Street Journal 07/11/2006
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05/23/2007
FDA's approach to approving drugs of pharmaceutical companies and weighing the risks and benefits.
07/01/2005
The questions of safety balanced by the need to let patients have access to drugs that would help them. The processes the FDA uses to arrive at proper decisions.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Says Two Eczema Products To Carry Cancer-Risk Warnings
Wall Street Journal 01/20/2006
Acting FDA Chief Asserts a Need To Review Drug-Approval Process
Wall Street Journal 09/26/2005
FDA Reviews of New Drugs May Signal Tougher Scrutiny
Wall Street Journal 08/23/2005
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
Improper influence on the FDA for approval of drugs.
07/10/2006
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Signals It's Open To Drug Trials That Shift Midcourse
Wall Street Journal 07/10/2006
F.D.A. Reveals It Fell to a Push by Lawmakers
New York Times 09/25/2009
FDA Panelists Had Ties to Bayer
Wall Street Journal 01/11/2012
New head of the FDA under the Obama administration and regulation of pharmaceutical companies.
07/10/2006
The change in direction at the FDA with the Obama administration and the new head of the FDA.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Signals It's Open To Drug Trials That Shift Midcourse
Wall Street Journal 07/10/2006
FDA to Hire Additional Scientists To Expand Drug Safety Operations
Wall Street Journal 04/30/2008
FDA Is Faulted for Oversight of Foreign Drugs
Wall Street Journal 10/22/2008
New FDA Leaders Could Be Tougher on Drug Makers
Wall Street Journal 11/06/2008
Lawmakers Divided Over Next FDA Head, Fixing Safety Issues
Wall Street Journal 12/05/2008
FDA Review Process for Medical Devices
09/24/2010
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
Wall Street Journal 02/15/2011
F.D.A. Faulted in Oversight of Risky Medical Devices
New York Times 04/12/2011
FDA's Drug Safety and Risk Management Committee.
05/21/2007
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
BusinessWeek 05/21/2007
A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA
Wall Street Journal 01/09/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us